MX2009006378A - Biomarcadores para cancer. - Google Patents

Biomarcadores para cancer.

Info

Publication number
MX2009006378A
MX2009006378A MX2009006378A MX2009006378A MX2009006378A MX 2009006378 A MX2009006378 A MX 2009006378A MX 2009006378 A MX2009006378 A MX 2009006378A MX 2009006378 A MX2009006378 A MX 2009006378A MX 2009006378 A MX2009006378 A MX 2009006378A
Authority
MX
Mexico
Prior art keywords
biomarker
cancer biomarkers
detecting
cancer
peptide
Prior art date
Application number
MX2009006378A
Other languages
English (en)
Spanish (es)
Inventor
Hardev Pandha
Richard George Leonard Morgan
Original Assignee
Univ Surrey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Surrey filed Critical Univ Surrey
Publication of MX2009006378A publication Critical patent/MX2009006378A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
MX2009006378A 2006-12-19 2007-12-19 Biomarcadores para cancer. MX2009006378A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0625321.5A GB0625321D0 (en) 2006-12-19 2006-12-19 Cancer biomarker
GBGB0719792.4A GB0719792D0 (en) 2006-12-19 2007-10-10 Cancer biomarkers
PCT/GB2007/004902 WO2008075056A1 (en) 2006-12-19 2007-12-19 Cancer biomarkers

Publications (1)

Publication Number Publication Date
MX2009006378A true MX2009006378A (es) 2009-08-24

Family

ID=39265269

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006378A MX2009006378A (es) 2006-12-19 2007-12-19 Biomarcadores para cancer.

Country Status (19)

Country Link
US (1) US8460882B2 (cg-RX-API-DMAC7.html)
EP (1) EP2115472B1 (cg-RX-API-DMAC7.html)
JP (1) JP5683108B2 (cg-RX-API-DMAC7.html)
CN (1) CN101675341B (cg-RX-API-DMAC7.html)
AU (1) AU2007335999B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0720371B8 (cg-RX-API-DMAC7.html)
CA (1) CA2671939C (cg-RX-API-DMAC7.html)
CY (1) CY1115178T1 (cg-RX-API-DMAC7.html)
DK (1) DK2115472T3 (cg-RX-API-DMAC7.html)
ES (1) ES2445185T3 (cg-RX-API-DMAC7.html)
GB (2) GB0625321D0 (cg-RX-API-DMAC7.html)
IL (1) IL199241A (cg-RX-API-DMAC7.html)
MX (1) MX2009006378A (cg-RX-API-DMAC7.html)
NZ (1) NZ577548A (cg-RX-API-DMAC7.html)
PL (1) PL2115472T3 (cg-RX-API-DMAC7.html)
PT (1) PT2115472E (cg-RX-API-DMAC7.html)
RU (1) RU2460075C2 (cg-RX-API-DMAC7.html)
SI (1) SI2115472T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008075056A1 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8461126B2 (en) 2005-10-14 2013-06-11 Phigenix, Inc. Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions
DE102006047617B4 (de) 2006-10-09 2008-11-27 Clariant International Limited Verfahren zur Herstellung basischer (Meth)acrylamide
DE102008017216B4 (de) 2008-04-04 2013-08-14 Clariant International Ltd. Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden
GB0823445D0 (en) * 2008-12-23 2009-01-28 Univ Surrey Biomarker
DE102009031059A1 (de) 2009-06-30 2011-01-05 Clariant International Ltd. Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen
GB0912175D0 (en) * 2009-07-13 2009-08-26 Univ Surrey Biomarker
EP2454597A1 (en) * 2009-07-13 2012-05-23 The University of Surrey Therapeutic peptides, polypeptides ans nucleic acid sequences
GB0912190D0 (en) * 2009-07-13 2009-08-26 Univ Surrey Biomarker
DE102009042522A1 (de) 2009-09-22 2011-04-07 Clariant International Ltd. Kontinuierliches Umesterungsverfahren
DE102009042523B4 (de) 2009-09-22 2012-02-16 Clariant International Ltd. Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen
GB0921329D0 (en) * 2009-12-04 2010-01-20 Univ Surrey Biomarker
DE102010056565A1 (de) 2010-12-30 2012-07-05 Clariant International Ltd. Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere
US20140106363A1 (en) * 2011-05-12 2014-04-17 Noviogendix Research B.V. Molecular markers in prostate cancer
AU2012252426A1 (en) * 2011-05-12 2013-11-28 Noviogendix Research B.V. Molecular markers in prostate cancer
CN103797120B (zh) * 2011-09-16 2017-04-12 上海长海医院 前列腺癌的生物学标志物、治疗靶点及其用途
MX2014006662A (es) * 2011-12-05 2015-04-16 Phigenix Inc Direccionamiento de en2, pax2, y/o defb1 para tratamiento de afecciones de la próstata.
US9110030B2 (en) 2012-06-29 2015-08-18 Daniel A. Kerschensteiner Colorimetric gelatinase assay
WO2014025961A1 (en) * 2012-08-10 2014-02-13 Analiza, Inc. Methods and devices for analyzing species to determine diseases
WO2014179959A1 (en) * 2013-05-09 2014-11-13 The Procter & Gamble Company Method and system for assessing health condition
WO2016102560A1 (en) * 2014-12-23 2016-06-30 The University Of Surrey Glycosylated biomarker
KR101698654B1 (ko) 2014-12-24 2017-01-20 포항공과대학교 산학협력단 En2에 특이적으로 결합하는 dna 압타머 및 이의 용도
DK3303616T3 (da) * 2015-05-29 2021-03-01 Koninklijke Philips Nv Fremgangsmåder til prognose af prostatakræft
US20190247461A1 (en) * 2015-09-23 2019-08-15 Centre National De La Recherche Scientifique Homeoproteins for use in the treatment of neurodegenerative disorders
CN106282347A (zh) * 2016-08-17 2017-01-04 中南大学 HoxC11作为生物标志物在制备肺腺癌的预诊断试剂中的应用
US10508287B2 (en) 2016-12-28 2019-12-17 Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences Method for regenerating T cells and applications thereof
KR101777085B1 (ko) * 2017-02-23 2017-09-11 주식회사 성균바이오텍 En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물
KR101777259B1 (ko) * 2017-07-14 2017-09-13 주식회사 무진메디 En2 단백질을 특이적으로 인식하는 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물
KR101777254B1 (ko) * 2017-07-14 2017-09-13 주식회사 무진메디 En2 단백질을 특이적으로 인식하는 특정 항원으로부터 얻어진 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물
CN107727729A (zh) * 2017-11-22 2018-02-23 南宁科城汇信息科技有限公司 一种oa候选标志物诊断模型的建立方法
CN107894507A (zh) * 2017-11-22 2018-04-10 南宁科城汇信息科技有限公司 一种发现和鉴定肝癌血清差异表达蛋白和验证标志物蛋白方法
KR101923199B1 (ko) 2018-04-25 2018-11-28 주식회사 무진메디 펩스타틴 a를 함유하는 소변 내 en2 진단용 조성물
CN111363817B (zh) * 2018-12-26 2024-02-02 广州康立明生物科技股份有限公司 基于hoxd12基因的肺癌诊断剂及试剂盒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002510974A (ja) * 1997-06-27 2002-04-09 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド ヒトｎｋ−３関連前立腺特異的遺伝子−１
RU2234942C2 (ru) * 1998-07-14 2004-08-27 Корикса Корпорейшн Выделенный опухолевый полипептид предстательной железы и кодирующий его полинуклеотид
WO2000023111A1 (en) * 1998-10-19 2000-04-27 Diadexus Llc Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1290442B1 (en) 2000-05-30 2013-11-13 Aarhus Universitet An assay method for testing plant material for exposure to herbicides using biomarkers
EP1297185A2 (en) * 2000-06-30 2003-04-02 Epigenomics AG Diagnosis of diseases associated with signal transduction
WO2002022884A2 (en) * 2000-09-12 2002-03-21 Transgenetics Incorporated Microarrayed organization of transcription factor target genes
NZ527180A (en) 2000-12-24 2007-02-23 Iser Lubocki A method for detecting biomarkers
US20040063216A1 (en) 2000-12-24 2004-04-01 Iser Lubocki Method for detecting biomarkers
WO2002070742A1 (en) * 2001-03-01 2002-09-12 Epigenomics Ag Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
US6949342B2 (en) * 2001-12-21 2005-09-27 Whitehead Institute For Biomedical Research Prostate cancer diagnosis and outcome prediction by expression analysis
CA2469089A1 (en) * 2003-07-08 2005-01-08 Institut De Recherches Cliniques De Montreal En-2 gene, disgnostic and therapeutic uses thereof
US20060014301A1 (en) 2004-07-13 2006-01-19 Power3 Medical Products, Inc. Antibody-based system for detection of differential protein expression patterns
AU2005322435B2 (en) * 2004-12-02 2012-02-23 Epigenomics Ag Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders
US9416422B2 (en) * 2005-02-18 2016-08-16 Sloan-Kettering Institute For Cancer Research Methods for detecting minimum residual disease

Also Published As

Publication number Publication date
AU2007335999A1 (en) 2008-06-26
SI2115472T1 (sl) 2014-05-30
GB0625321D0 (en) 2007-01-24
PL2115472T3 (pl) 2014-05-30
GB0719792D0 (en) 2007-11-21
CA2671939C (en) 2017-10-03
JP2010513901A (ja) 2010-04-30
NZ577548A (en) 2012-03-30
WO2008075056A1 (en) 2008-06-26
BRPI0720371A2 (pt) 2013-12-31
BRPI0720371B8 (pt) 2021-07-27
RU2009127774A (ru) 2011-01-27
CY1115178T1 (el) 2016-12-14
JP5683108B2 (ja) 2015-03-11
CN101675341A (zh) 2010-03-17
AU2007335999B2 (en) 2013-09-05
EP2115472A1 (en) 2009-11-11
CN101675341B (zh) 2017-08-08
BRPI0720371B1 (pt) 2019-05-28
EP2115472B1 (en) 2013-11-06
DK2115472T3 (da) 2014-02-10
CA2671939A1 (en) 2008-06-26
ES2445185T3 (es) 2014-02-28
US20100093558A1 (en) 2010-04-15
PT2115472E (pt) 2014-02-14
IL199241A (en) 2014-03-31
US8460882B2 (en) 2013-06-11
RU2460075C2 (ru) 2012-08-27

Similar Documents

Publication Publication Date Title
MX2009006378A (es) Biomarcadores para cancer.
WO2008061104A3 (en) Methods and kits for detecting prostate cancer biomarkers
WO2010009337A3 (en) Signatures and pcdeterminants associated with prostate cancer and methods of use thereof
WO2008097908A3 (en) Methods of diagnosing and prognosing lung cancer
WO2009036427A3 (en) Prostate cancer biomarkers
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
WO2007093657A3 (es) Método para el diagnóstico molecular de cáncer de próstata y kit para implementar el método
WO2009158620A3 (en) Signatures and determinants associated with metastasis methods of use thereof
MX2008011185A (es) Marcadores para adiccion.
WO2007082154A3 (en) B7-h1 and b7-h4 in cancer
WO2007081720A3 (en) Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
IL233098A (en) Cancer Detection and Prognosis Methods and Survival Probabilities and Biomarkers Based on Their Use
WO2010125566A3 (en) Markers for cancer detection
WO2010146059A3 (en) Biomarkers for igf-1r inhibitor therapy
WO2008128169A8 (en) Sparc and methods of use thereof
WO2008097466A3 (en) Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors
WO2008002672A3 (en) Targets for use in diagnosis, prognosis and therapy of cancer
MX2007013727A (es) Caracterizacion de cancer de prostata.
MX2007004342A (es) Moleculas cop1 y uso de las mismas.
TNSN08401A1 (en) Methods of treating diagnosing or detecting cancer
ATE513216T1 (de) Verwendung des proteins satb2 als prognostischer marker für kolorektalkarzinome
WO2010009171A3 (en) Src activation for determining cancer prognosis and as a target for cancer therapy
WO2008086002A3 (en) Slco1b3 genotype
WO2009085196A8 (en) Methods and compositions for correlating genetic markers with prostate cancer risk
WO2010053816A3 (en) Biomarkers for diagnosis of breast cancer

Legal Events

Date Code Title Description
FG Grant or registration